The diagnosis, treatment and co-morbidity management of diabetes is costly, and this is expected only to rise even higher every year. Knowing why certain interventions are necessary, and why our medical products can lower disease and co-morbidity costs in a revolutionary new way is key to yield a more sustainable and affordable health care system.
